Federal Cannabis Legislation and Regulation. Attend this session for an overview of developments in federal cannabis legislation and regulation. Panelists will address new bills, reintroductions, and what is likely to move.
Attendees will leave this panel with a deeper understanding of the current hemp and CBD legislation and proposed legislative solutions to current regulatory and legal challenges facing the hemp and hemp-derived cannabinoid industries. Panelists will do a deep dive into current legislative proposals, as well as approaches for the 2023 Farm Bill.
Medical Cannabis: Overview of Emerging Legal Issues and their Impact on the International Market. The international panel of experts will notably discuss the differences in regulations between medical cannabis and pharmaceutical cannabis, how IP is becoming an essential topic with pharmaceutical cannabis medicines, and how it could also impact medical cannabis in the short run.
Navigating the Highs and Lows of Cannabis Regulatory Compliance—Insights, Best Practices, and Hurdles. Examine regulatory compliance “hot topics”, including maintaining state licenses and navigating enforcement actions, and explore best practices for corporate governance, novel partnership agreements such as IP licensing and white labeling, and regulatory considerations of various exit strategies for mature cannabis enterprises.
Cannabis law and policy continue to quickly evolve and the past year has seen major legal developments for the regulated marijuana and hemp industries. Moderated by Paul Demko, Cannabis Editor at POLITICO, this panel of experts bring their broad legal and policy perspectives to identify and comment upon important court rulings and litigation trends, as well as anticipated changes to the law heading into 2024 on a variety of legal topics.
In this CLE, you will learn about best practices and how to avoid common pitfalls in the rules of professional conduct. The panel will also provide an update on current proposals growing out of the attorney-as-gatekeeper discussion.
Focusing on the Cannabis Administration and Opportunity Act (CAOA), the Marijuana Opportunity Reinvestment and Expungement Act (MORE), and the States Reform Act (SRA), our panelists will discuss how these proposals would change how the the relevant agencies (such as USDA, FDA, TTB, and PTO) regulate the cannabis sector.
With legalization initiatives moving quickly in the Tri-State Area, prospective operators are gearing up for what will inevitably be a competitive licensing process. In this session, attorneys will delve into the laws in: New Jersey, New York, and Connecticut.